Navigation Links
pTriEx™-4 DNA from Novagen

ProductspTriEx™-4 DNA from Novagen
Company Novagen
Item pTriEx™-4 DNA
Price $228.00
Description The pTriEx™ vectors combine the proven features of the pET, BacVector® and mammalian systems and provides all of the benefits and versatility of each expression system in one vector backbone. The pTriEx vectors have been extensively tested for performance with various target genes in all three expression systems. In each case, expression was similar to that obtained with system-specific vectors. The pTriEx™-4 vector1 is uniquely designed to allow rapid characterization of target genes in multiple expression systems. With this vector a single recombinant plasmid can be used to test expression in E. coli, insect and vertebrate cells. Transient vertebrate expression is mediated by the CMV immediate early enhancer and promoter2. For expression in insect cells, pTriEx-4 contains flanking baculovirus sequences to permit the generation of recombinant baculoviruses using the BacVector™ System. In baculovirus-infected insect cells, expression is driven by the very late p10 promoter. Expression in E. coli is regulated by the tightly controlled T7lac promoter. Expression can be induced in hosts such as NovaBlue by infecting with λCE6, a phage that constitutively expresses T7 RNA polymerase from the λpL and λlpI promoters. Alternatively, pTriEx recombinant plasmids can be transferred into a (DE3)pLacI host that allows IPTG based induction. Native protein can be expressed by cloning into the NcoI site, or native protein can be generated by cloning into the PshAI or SmaI sites and cleavage of the fusion protein with Enterokinase or Thrombin, respectively. The pTriEx-4 vector is also available as an Ek/LIC Cloning Kit.
1 patent pending
2 The CMV promoter is covered by U.S. Patent nos. 5,168,062 and 5,385,839 issued to the University of Iowa Research Foundation and is licensed for research use only.
Info NovagenNovagen
441 Charmany Drive
Madison, WI 53719
Customer Service: 800-526-7319
Tech Support: 800-207-0144
Fax Number: 608-238-1388
Web Site: http://www.novagen.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. S-Protein Agarose from Novagen
2. STag Thrombin Purification Kit from Novagen
3. S-Protein Agarose from Novagen
4. S-Protein Agarose from Novagen
5. pET GST Fusion System 42 plus Competent Cells from Novagen
6. pET GST Fusion System 42 from Novagen
7. pET GST Fusion System 41 plus Competent Cells from Novagen
8. pET GST Fusion System 41 from Novagen
9. GST•Tag™ Antibody Plate from Novagen
10. Mouse Anti-GST Tag Monoclonal Antibody, Unconjugated from Novagen
11. pETcoco-1 System from Novagen
...hase extraction through columns is a well-known se.... Typical applications are in DNA/RNA extraction i..., or compound purification in chemical or analytic...n the Genesis series instruments for smaller scale...
...is Tecan's pipetting software for life science app...the GENESIS WORKSTATION instruments including the ...ware enables the user the simple graphical configu...pts. With the powerful scripting language the most...
POLYCLONAL ANTIBODY PRODUCTION from Global Peptide Services, LLC.
...Genomics Solution is a comprehensive suite of adva... specifically designed to reliably extract biologi...nal genomic studies containing thousands of sample...ent and will analyze large data sets on a personal...
Biology Products:
(Date:11/26/2009)...lberg, 27 November 2009 What are the bare essenti...d to produce a cell that can survive on its own? C...d understand how an entire organism functions as a... scientists in a partnership between the European ... Germany, and the Centre de Regulacio Genmica (CRG...
(Date:11/25/2009)...a hormone produced in the stomach, may be used to ...arkinson,s disease, Yale School of Medicine resear...e of the Journal of Neuroscience . , Parkinson,...neurons in an area of the midbrain known as the su...production. Reduced production of dopamine in lat...
(Date:11/25/2009)...it Larisch, Head of the Cell Death Research Labora...ology, has been awarded the prestigious Johnson & ...loring the cause of brain cell damage in Parkinson...to scientists in support of innovation and excelle...lly conferred earlier this month at an event at th...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Hormone ghrelin can boost resistance to Parkinson's disease 2Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cance 58487 1Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cance 58487 2Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cance 58487 3Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cance 58487 4Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cance 58487 5Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cance 58487 6Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO 5076 1Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO 5076 2Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO 5076 3Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call 3B October 1 2009 at 4 3A30 p m Eastern 5072 1Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call 3B October 1 2009 at 4 3A30 p m Eastern 5072 2
...mon laboratory test that predicted poor outcome fr...t for head and neck cancers now has been found to ...or suppressor gene therapy - making it potentially...sed drug. , Researchers at Introgen Therapeutics, ...dvanced squamous cell carcinoma of the head and ne...
...ublic Library of Science (PLoS) announced today th...e first open access journal devoted to the world,s...al Diseases ( www.plosntds.org ) will focus on the...e every year in poor countries, including elephant...somiasis, and African sleeping sickness. The jour...
...e addicted to cocaine have an impaired ability to ...ptions in the brain,s reward and control circuits,...d neuropsychological tests conducted at the U.S. D...ry. , "Our findings provide the first evidence tha... rewards is modified in drug-addicted people, and ...
Other Biology News:Abnormal overexpression of p53 is a predictive molecular biomarker 2Public Library of Science to launch new, open access journal on neglected tropical diseases 2Public Library of Science to launch new, open access journal on neglected tropical diseases 3Altered perception of reward in human cocaine addiction 2Altered perception of reward in human cocaine addiction 3
(Date:11/24/2009)... , REYKJAVIK, Iceland, Novem...Inc. (Nasdaq: DCGN ) today announced the approval ...ruptcy Court for the District of Delaware,(the "Ba...ry petition for,relief under Chapter 11 of the Uni...rt. , The orders issued by the Bankruptcy...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asi... Food & Drug Administration (SFDA) has approve...or its oral insulin project,(Nodlin), an innovativ...approval allows Biolaxy to initiate its first phas...der characteristic of high blood glucose and poor,...
(Date:11/24/2009)... , , Primary efficacy endpoint has been m...nt endometrial cancer, , QUEBEC CITY, Nov. 24...ASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global...erapy and oncology, today announced positive effic...totoxic peptide conjugate, AEZS-108 (formerly AN-1...
(Date:11/24/2009)... , SAN DIEGO, Nov. 24, 2009 /PRNewswire-F... ARNA ) announced today that the company is sche...Health Care Conference on December 1, 2009 at 11:3...e New York Palace Hotel in New York City. Jack Lie...is scheduled to provide an overview of the company...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3